Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.
Greg Freiherr

Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applications. But a new entrant, “mixed reality,” may have the inside track in the interventional suite or operating room.
WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography.
Greg Freiherr

Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in echocardiograpy. And machine learning, which is part of artificial intelligence (AI), is just getting started.

March 15, 2019 – Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of patients with cardiac arrhythmias. The six new tachycardia solutions include Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX Bipolar and Acticor CRT-DX.

The American College of Cardiology’s first annual ACC Quality Summit, held March 13-15 in New Orleans, merges the NCDR (National Cardiovascular Data Registry) Annual Conference and ACC Accreditation Congress for the first time to optimize cardiovascular patient care. The conference brings together cardiovascular thought leaders, administrators, clinicians, clinical quality leaders and data quality experts.

March 15, 2019 — Artificial intelligence (AI) company Bay Labs announced the presentation of two studies assessing performance of the company’s deep learning software for cardiovascular imaging.

Debate About Coronary Testing Highlights ACC Session

March 14, 2019 — Beginning in mid-2019, hospitals performing transcatheter valve repair and replacement will be able to apply for the American College of Cardiology’s new Transcatheter Valve Certification. The certification was announced at the American College of Cardiology (ACC) Quality Summit in New Orleans.

Siemens Healthineers will introduce the Somatom go.Top Cardiovascular Edition, a new version of its established computed tomography (CT) system, at the 68th Annual Scientific Session and Expo of the American College of Cardiology (ACC), March 16-18 in New Orleans. The Somatom Go.Top Cardiovascular Edition is designed to deliver personalized patient dose control in all types of routine cardiovascular imaging. The cost-effective, 128-slice scanner offers outpatient cardiology offices as well as hospitals access to not just coronary CT angiography (CCTA), but also advanced tests, including the HeartFlow FFRCT (fractional flow reserve computed tomography) Analysis.

13th International Symposium on Endovascular Therapeutics

FDA Approves MitraClip for Use in Heart Failure Patients With Functional Mitral Regurgitation

March 14, 2019 — The U.S. Food and Drug Administration (FDA) approved the MitraClip heart valve repair device for patients with heart failure symptoms and moderate-to-severe or severe mitral regurgitation (MR) due to diminished left heart function, commonly known as secondary or functional MR, despite optimal medical therapy.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now